These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2872765)

  • 1. The effect of beta-adrenergic blockade on the myopathic changes in experimental hyperthyroidism in rats.
    Angerås U; Oldfors A; Hasselgren PO
    Acta Pathol Microbiol Immunol Scand A; 1986 Mar; 94(2):91-9. PubMed ID: 2872765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein degradation in skeletal muscle during experimental hyperthyroidism in rats and the effect of beta-blocking agents.
    Angerås U; Hasselgren PO
    Endocrinology; 1987 Apr; 120(4):1417-21. PubMed ID: 2881774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of propranolol, atenolol and metoprolol on the serum levels of thyroxin (T4) and triiodothyronine (T3).
    Shikara MM; Maniar R; Steier W; Rao S; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():127. PubMed ID: 14699907
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of beta-blocking agents on urinary excretion of 3-methylhistidine during experimental hyperthyroidism in rats.
    Angerås U; Jagenburg R; Lindstedt G; Hasselgren PO
    Eur Surg Res; 1987; 19(1):23-30. PubMed ID: 2878810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thyroid hormone and beta-blocking agents on plasma amino acids in rats.
    Angerås U; Jagenburg R; Hasselgren PO
    Acta Chir Scand; 1986 May; 152():339-45. PubMed ID: 3739542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients.
    Nilsson OR; Melander A; Tegler L
    Eur J Clin Pharmacol; 1980 Oct; 18(4):315-20. PubMed ID: 7439251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism.
    Perrild H; Hansen JM; Skovsted L; Christensen LK
    Clin Endocrinol (Oxf); 1983 Feb; 18(2):139-42. PubMed ID: 6133659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen consumption in patients with hyperthyroidism before and after treatment with beta-blockade versus thyrostatic treatment: a prospective randomized study.
    Jansson S; Lie-Karlsen K; Stenqvist O; Körner U; Lundholm K; Tisell LE
    Ann Surg; 2001 Jan; 233(1):60-4. PubMed ID: 11141226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
    Shikara MM; Polena S; Solinas A; Sanghvi K; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():125-6. PubMed ID: 14699906
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of beta-blocking agents in hyperthyroidism.
    Földes J; Bános C; Borvendég J; Gyertyánfy G
    Acta Med Acad Sci Hung; 1979; 36(4):375-80. PubMed ID: 45285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortisol, growth hormone and prolactin responses to insulin-induced hypoglycaemia in hyperthyroid patients before and during beta-adrenoceptor blockade.
    Nilsson OR; Anderberg B; Karlberg BE; Kågedal B
    Clin Endocrinol (Oxf); 1980 Jun; 12(6):581-8. PubMed ID: 6105025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of beta-adrenoceptor blocking drugs in hyperthyroidism.
    Feely J; Peden N
    Drugs; 1984 May; 27(5):425-46. PubMed ID: 6144501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The heart and hyperthyroidism. Use of beta-adrenergic blocking drugs.
    Levey GS
    Med Clin North Am; 1975 Sep; 59(5):1193-9. PubMed ID: 240093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol induced reduction in serum T3-A biochemical index of beta-adrenergic blockade in hyperthyroidism.
    Feely J
    Horm Metab Res; 1980; 12(6):279-80. PubMed ID: 6105995
    [No Abstract]   [Full Text] [Related]  

  • 15. Thyrotoxic myopathy. Pathomorphological observations of human material and experimentally induced thyrotoxicosis in rats.
    Korényi-Both A; Korényi-Both I; Kayes BC
    Acta Neuropathol; 1981; 53(3):237-48. PubMed ID: 7223366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.
    Prida XE; Feldman RL; Hill JA; Pepine CJ
    Am J Cardiol; 1987 Aug; 60(4):244-8. PubMed ID: 2887101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative influence of propranolol and verapamil on glycemic control and histamine sensitivity associated with L-thyroxine-induced hyperthyroidism - an experimental study.
    Bhatt PA; Makwana D
    Fundam Clin Pharmacol; 2008 Feb; 22(1):53-9. PubMed ID: 18251722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein metabolism in skeletal muscle tissue from hyperthyroid patients after preoperative treatment with antithyroid drug or selective beta-blocking agent. Results from a prospective, randomized study.
    Hasselgren PO; Adlerberth A; Angerås U; Stenström G
    J Clin Endocrinol Metab; 1984 Nov; 59(5):835-9. PubMed ID: 6207197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative treatment of thyrotoxicosis with a beta-adrenergic blocking agent.
    Ljunggren JG; Persson B
    Acta Chir Scand; 1975; 141(8):715-8. PubMed ID: 3081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of propranolol and metoprolol in the management of hyperthyroidism.
    Murchison LE; How J; Bewsher PD
    Br J Clin Pharmacol; 1979 Dec; 8(6):581-7. PubMed ID: 391258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.